Zikria Dean
SEC insider (Form 3/4/5 filer). CIK 0001877611. Interim CEO at Valion Bio, Inc. (VBIO). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 22, 2026. Located in SAN ANTONIO, TX.
Companies Zikria Dean has filed insider reports for
- Valion Bio, Inc. (VBIO): Director, Officer, Interim CEO
Zikria Dean
CIK: 0001877611
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VBIO
Valion Bio, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 22, 2026VBIO
Valion Bio, Inc.
AwardDirectRestricted Stock Units
50K shares- - Aug 6, 2025TIVC
Tivic Health Systems, Inc.
AwardDirectStock Option (Right to Purchase)
7.5K shares- - Dec 18, 2024TIVC
Tivic Health Systems, Inc.
AwardDirectStock Option (Right to Purchase)
12K shares-
1-3 of 3 transactions